Search research articles
Contact Us
Filters
Showing results (11-20 of 342) with videos related to
Page
of 35
Sort By:
Oncology Research and Treatment
|
May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]
Axel Hauschild, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 1, 2006
[Brief guideline--cutaneous neuroendocrine carcinoma (Merkel cell carcinoma]
Axel Hauschild, Claus Garbe
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 26, 2019
Axel Hauschild, Dirk Schadendorf
Nature Reviews. Clinical Oncology
|
January 15, 2014
Melanoma in 2013: Melanoma--the run of success continues
Dirk Schadendorf, Axel Hauschild
Oncology Research and Treatment
|
October 26, 2016
[Vorwort]
Axel Hauschild, Dirk Schadendorf
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 19, 2010
Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma
Katharina C Kähler, Axel Hauschild
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2013
Reply to K.S. Wilson et al
Antoni Ribas, Axel Hauschild, Richard Kefford
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 11, 2008
Recent aspects of medical care of malignant melanoma
Patrick Terheyden, Wolfgang Tilgen, Axel Hauschild
Experimental Dermatology
|
March 4, 2008
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
Paul Lorigan, Tim Eisen, Axel Hauschild
The New England Journal of Medicine
|
April 4, 2019
Estimation of Distant Metastasis-free Survival in Trials of Adjuvant Therapy for Melanoma. Reply
Georgina V Long, Eduard Gasal, Axel Hauschild
Page
of 35
Search research articles
Search
Showing results (11-20 of 342) with videos related to
Sort By:
Page
of 35
Oncology Research and Treatment
|
May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]
Axel Hauschild, Peter Mohr
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 1, 2006
[Brief guideline--cutaneous neuroendocrine carcinoma (Merkel cell carcinoma]
Axel Hauschild, Claus Garbe
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 26, 2019
Axel Hauschild, Dirk Schadendorf
Nature Reviews. Clinical Oncology
|
January 15, 2014
Melanoma in 2013: Melanoma--the run of success continues
Dirk Schadendorf, Axel Hauschild
Oncology Research and Treatment
|
October 26, 2016
[Vorwort]
Axel Hauschild, Dirk Schadendorf
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 19, 2010
Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma
Katharina C Kähler, Axel Hauschild
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2013
Reply to K.S. Wilson et al
Antoni Ribas, Axel Hauschild, Richard Kefford
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 11, 2008
Recent aspects of medical care of malignant melanoma
Patrick Terheyden, Wolfgang Tilgen, Axel Hauschild
Experimental Dermatology
|
March 4, 2008
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
Paul Lorigan, Tim Eisen, Axel Hauschild
The New England Journal of Medicine
|
April 4, 2019
Estimation of Distant Metastasis-free Survival in Trials of Adjuvant Therapy for Melanoma. Reply
Georgina V Long, Eduard Gasal, Axel Hauschild
Page
of 35